Intelligence Platform
Patents
Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7321063
Sulfonamide inhibitors of aspartyl protease
granted patentUS 7314885
Pyrrole compounds useful as kinase inhibitors
granted patentUS 7312226
Substituted tricyclic compounds as protein kinase inhibitors
granted patentUS 7312227
Compositions useful as inhibitors of JAK and other protein kinases
granted patentUS 7306799
Use of VEGF inhibitors for treatment of eye disorders
granted patentUS 7304071
Protein kinase inhibitors and uses thereof
granted patentUS 7304061
Heterocyclic inhibitors of ERK2 and uses thereof
granted patentUS 7303747
Use of VEGF inhibitors for treatment of eye disorders
granted patentUS 7288624
Inhibitors of interleukin-1Ξ² converting enzyme
granted patentUS 7285556
Thienopyrimidine-based inhibitors of the src family
granted patentUS 7279469
Diaminotriazoles useful as inhibitors of protein kinases
granted patentUS 7279476
Pyrazole-derived kinase inhibitors and uses thereof
granted patentUS 7276502
Thiazoles useful as inhibitors of protein kinases
granted patentUS 7276348
Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
granted patentUS 7273851
Tri-peptide hepatitis C serine protease inhibitors
granted patentUS 7273885
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted patentUS 7271186
Nanomolar Ξ²-lactamase inhibitors
granted patentUS 7271181
Inhibitors of p38
granted patentUS 7271179
Inhibitors of JAK protein kinase
granted patentUS 7268122
Use of oversulfated polysaccharides as inhibitors of HIV
granted patentUS 7268136
Compositions useful as inhibitors of protein kinases
granted patentUS 7259161
Compositions useful as inhibitors of JAK and other protein kinases
granted patentUS 7259142
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target
granted patentUS 7256190
Thiazole compounds useful as inhibitors of protein kinase
granted